![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J Biol Chem, Vol. 275, Issue 18, 13167-13170, May 5, 2000
From the Department of Molecular Biology and Biochemistry, Osaka University Graduate School of Medicine/Faculty of Medicine, Suita 565-0871, Japan
| |
ABSTRACT |
|---|
|
|
|---|
Rab11a small G protein (Rab11p) is
implicated in vesicle trafficking, especially vesicle recycling. We
have previously isolated a downstream effector of Rab11p, named
rabphilin-11. We found here that rabphilin-11 directly bound the
mammalian counterpart of yeast Sec13 protein (mSec13p) in cell-free and
intact cell systems. Yeast Sec13p is involved as a component of coat
proteins II in the Sar1p-induced vesicle formation from the endoplasmic reticulum, but the precise role of mSec13p is unknown. The interaction of rabphilin-11 with mSec13p was enhanced by GTP-Rab11p. Rabphilin-11 localized on the vesicles in perinuclear regions and along microtubules oriented toward the plasma membrane, whereas mSec13p partly colocalized with rabphilin-11 in the perinuclear regions, most presumably the Golgi
complex. Disruption of the rabphilin-11-mSec13p interaction by
overexpression of the mSec13p-binding region of rabphilin-11 impaired
vesicle trafficking. These results indicate that the rabphilin-11-mSec13p interaction is implicated in vesicle trafficking.
Rab11p is a Rab small G protein family member that localizes to
early endosomes, recycling endosomes, the trans-Golgi
network membranes, and the post-Golgi secretory vesicles and regulates vesicle trafficking, especially vesicle recycling (1-7). Zeng et
al. (8) and we (9) have independently isolated the same downstream
effector of Rab11p from bovine and rat, named Rab11BP and rabphilin-11,
respectively. Rab11BP/rabphilin-11 (rabphilin-11) consists of 908 aa1 and contains one
proline-rich region and six WD-40 repeats in addition to a
Rab11p-binding domain. Free rabphilin-11 localizes in the cytosol, but
upon binding to GTP-Rab11p, rabphilin-11 localizes to early endosomes,
recycling endosomes, and the Golgi complex, as well as along
microtubules oriented toward lamellipodia (9), suggesting that
GTP-Rab11p recruits rabphilin-11 to these membranes and exerts its
function through rabphilin-11. However, the mode of action of the
Rab11p-rabphilin-11 system in vesicle trafficking remains to be
clarified. We searched here for a rabphilin-11-interacting molecule(s)
by the yeast two-hybrid method and identified it as a mammalian
counterpart of the yeast Sec13 protein (Sec13p).
Yeast Sec13p is involved as a component of the COPII of the vesicles
that bud from the ER in a Sar1p-dependent manner (10-12). When GDP-Sar1p is converted to GTP-Sar1p by the action of Sec12p, a
GDP/GTP exchange protein of Sar1p (13-15), Sec23 and Sec24p are recruited to the membrane of the ER followed by recruitment of Sec13p
and Sec31p, causing bud formation (12, 16, 17). When GTP-Sar1p is
converted to GDP-Sar1p by the action of Sec23p, a GTPase-activating
protein of Sar1p (18), the coated vesicles are uncoated (12, 17, 18).
The mammalian counterpart of yeast Sec13p (mSec13p) has been isolated
(19), but its precise role or mode of action remains unknown.
We describe here the rabphilin-11-mSec13p interaction and its role in
vesicle trafficking.
Yeast Two-hybrid Assay--
Yeast transformations were performed
by the lithium acetate method (20). Yeast transformants were selected
in dextrose-containing selection (SD) medium (21). The yeast reporter
strain L40 expressing pLexA-rabphilin-11-1 (1-631 aa) was transformed
with a human T cell cDNA library (MATCHMAKER human T cell
oligo(dT)-primed library in pACT, CLONTECH). About
1.0 × 106 transformants were screened, and library
plasmids from 16 positive clones were analyzed by transformation tests
and DNA sequencing (22, 23). Preparation of Recombinant Proteins--
Standard molecular
biological techniques were used for construction of plasmids, DNA
sequencing, and polymerase chain reaction (25). The cDNA fragments
encoding several rabphilin-11 deletion mutants were inserted into
pBTM116, encoding the DNA-binding domain of LexA: pLexA-rabphilin-11-1
(1-631 aa), -2 (300-631 aa), -3 (504-631 aa), -4 (632-908 aa), -5 (300-504 aa), -6 (607-730 aa), and -full (1-908 aa). The cDNA
fragments encoding several mSec13p deletion mutants were inserted into
pGAD424, encoding transcriptional activation domain of GAL4. The
cDNA fragments encoding a dominant active mutant of Rab11p
(Rab11pQ70L Assay for Rabphilin-11-mSec13p Interaction in
Vitro--
Rabphilin-11-full and rabphilin-11-1 (1-631 aa) were
in vitro translated using the TNT T7-coupled reticulocyte
lysate system (Promega Corp.) and incubated with MBP or MBP-tagged
mSec13p (100 pmol) prebound to an amylose resin column in buffer A (20 mM Tris/HCl, pH 7.5, 1 mM EDTA, 1 mM dithiothreitol, 1% Nonidet P-40, and 150 mM
NaCl) at 4 °C for 90 min. After the beads were washed four times
with the same buffer, the bound proteins were eluted by adding 100 µl
of buffer A containing 10 mM maltose. The eluates were
subjected to SDS-PAGE followed by autoradiography. The mouse brain
cytosol was subjected to immunoprecipitation with 10 pmol of the
anti-mSec13p antibody or the preimmune rabbit polyclonal antibody bound
to 20 µl of protein A-Sepharose beads (Amersham Pharmacia Biotech).
Comparable amounts of the pellets were subjected to SDS-PAGE followed
by immunoblotting with the anti-rabphilin-11 antibody. The antibodies
used here were prepared as described below.
Cell Culture and Transfection--
HeLa cells and BHK
cells were supplied by Dr. S. Orita (Discovery Research Laboratory,
Shionogi & Co. Ltd., Osaka, Japan). Both HeLa cells and BHK cells were
cultured at 37 °C with a humidified atmosphere of 5%
CO2 and 95% air in Dulbecco's modified Eagle's medium
containing 10% fetal calf serum (Life Technologies, Inc.), 100 units/ml of penicillin, and 100 µg/ml of streptomycin. These cells
were transiently transfected with the plasmids encoding the indicated
proteins by use of Superfect reagent (Qiagen).
Antibodies and Immunofluorescence Staining--
A rabbit
polyclonal antibody against mSec13p was raised against glutathione
S-transferase-tagged mSec13p. The antiserum was affinity-purified with MBP-tagged mSec13p covalently coupled to CNBr-activated Sepharose beads (Amersham Pharmacia Biotech). An anti-rabphilin-11 antibody was obtained as described (9). Hybridoma cells expressing the mouse monoclonal anti-Myc antibody (9E10) were
purchased from American Type Culture Collection (Manassas, VA). An
anti-Golgi p58 antibody was purchased from Sigma. An anti-Calnexin antibody was purchased from StressGenn Biotechnologies Corp. (Victoria, Canada). Second antibodies for immunofluorescence microscopy were obtained from Chemicon International, Inc. (Temecula, CA).
Immunofluorescence staining was performed as described (9). The cells
were examined by use of an Eclipse E800 immunofluorescence microscope
(Nikon, Tokyo, Japan).
Exocytosis of VSV G Proteins--
Equal amounts of the plasmids
encoding several rabphilin-11 deletion mutants and GFP-tagged VSV G
protein were used for cotransfection experiments. After 17 h,
transfected BHK cells were incubated at 20 °C for 2 h. Parallel
samples were transferred to 37 °C for 1 h immediately after
incubation at 20 °C. Cells were then fixed and examined by
immunofluorescence microscopy.
We first attempted to isolate a rabphilin-11-interacting
protein(s) by use of the yeast two-hybrid method with the N-terminal fragment (rabphilin-11-1, 1-631 aa) as a bait from a human T cell cDNA library. Screening of 1 × 106 transformants
yielded 16 positive clones, and 6 of these clones encoded full-length
mSec13p. One of the six clones was selected for further analysis. The
selected clone (clone 5) indeed interacted with rabphilin-11-1 (Fig.
1A). This clone also
interacted with full-length rabphilin-11 (rabphilin-11-full), to a
lesser extent, but did not interact with the C-terminal fragment
(rabphilin-11-4, 632-908 aa) (Fig. 1A).
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-Galactosidase activity was measured by
liquid and filter assays (23, 24). Where indicated, cotransformation was performed into yeast strain TAT7.
C, 1-211 aa) and a dominant negative mutant of Rab11p
(Rab11pT25N
C, 1-211 aa) were inserted into pGAD424. These Rab11ps
did not possess the C-terminal lipid modification site to prevent
association of Rab11p with the membranes (21). The cDNA fragment of
full-length mSec13p was inserted into pMALC2 (New England BioLabs,
Inc., Beverly, MA) and pGEX-4T-1 (Amersham Pharmacia Biotech) vectors.
Mammalian expression plasmids were constructed by inserting full-length
mSec13p and various truncated fragments of rabphilin-11 into pCIneo
(Promega Corp., Madison, WI).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (46K):
[in a new window]
Fig. 1.
Rabphilin-11-mSec13p interaction in cell-free
and intact cell systems. A, rabphilin-11-mSec13p
interaction estimated by the yeast two-hybrid method. Yeast strain L40
expressing pLexA-rabphilin-11-1 (1-631 aa), -4 (632-908 aa), or -full
was transformed with a plasmid encoding pACTII (vector) or pACT-clone
5.
-Galactosidase activity of resultant transformants was assayed.
B, rabphilin-11-mSec13p interaction in a cell-free system.
In vitro translated [35S]methionine-labeled
rabphilin-11-1 (1-631 aa) or rabphiin-11-full was incubated with MBP
or MBP-tagged mSec13p prebound to an amylose resin column. The bound
proteins were subsequently eluted with maltose, and the eluted proteins
were subjected to SDS-PAGE followed by autoradiography. a,
rabphilin-11-1; b, rabphilin-11-full. C,
coimmunoprecipitation of rabphilin-11 with mSec13p. The mouse brain
cytosol was incubated with the anti-mSec13p antibody or the preimmune
rabbit polyclonal antibody immobilized on protein A-Sepharose beads.
The immunoprecipitates were subjected to SDS-PAGE followed by
immunoblotting with the anti-rabphilin-11 antibody.
To examine whether rabphilin-11 directly interacts with mSec13p,
the binding of in vitro translated
[35S]methionine-labeled rabphilin-11-1 (1-631 aa) or
rabphilin-11-full to MBP-tagged recombinant mSec13p was examined. Both
rabphilin-11-1 and rabphilin-11-full directly interacted with mSec13p
(Fig. 1B, a and b). The interaction of
rabphilin-11 with mSec13p was confirmed by coimmunoprecipitation from
the mouse brain cytosol (Fig. 1C). Moreover, subcellular
localization analysis in HeLa cells showed that overexpressed
Myc-tagged mSec13p localized at the ER and the Golgi complex (Fig.
2, A and B),
whereas endogenous rabphilin-11 localized in perinuclear regions and
along microtubules oriented toward the plasma membrane; Myc-tagged
mSec13p and rabphilin-11 colocalized in perinuclear regions, most
presumably the Golgi complex (Fig. 2C). Essentially
equivalent results were obtained in BHK cells and Madin-Darby canine
kidney cells (data not shown). These results suggest that rabphilin-11
directly interacts with mSec13p in both cell-free and intact cell
systems.
|
We next studied the mSec13p-binding region of rabphilin-11 by the yeast
two-hybrid method. Rabphilin-11-full interacted with mSec13p to some
extent, but the region (rabphilin-11-3, 504-631 aa) that contains the
second and third WD-40 repeats and is located next to the
Rab11p-binding region (300-504 aa), interacted with mSec13p to a
greater extent (Fig. 3A).
Other regions, excluding this region, did not interact with mSec13p.
These results suggest that a region(s) other than the mSec13p-binding
region masks this region, thereby hindering the interaction with
mSec13p, and that another factor is necessary to open this folded
structure.
|
We next examined the effect of Rab11p on the rabphilin-11-mSec13p
interaction by the yeast two-hybrid method. The
rabphilin-11-full-mSec13p interaction was greater upon coexpression
with a dominant active mutant of Rab11p (Rab11pQ70L
C) than upon
coexpression with a dominant negative mutant of Rab11p (Rab11pT25N
C)
or with no expression of these mutants (Fig. 3B),
suggesting that the rabphilin-11-full-mSec13p interaction is enhanced
by the binding of GTP-Rab11p to rabphilin-11. This enhancement,
however, did not reach the level of the rabphilin-11-3-mSec13p interaction.
We attempted to determine the rabphilin-11-binding region of mSec13p by the same method. The N-terminal one-third (1-187 aa), the middle one-third (135-249 aa), or the C-terminal one-third (249-323 aa) of mSec13p did not interact with rabphilin-11-2 (300-631 aa) (data not shown), suggesting that the whole structure of mSec13p is necessary for the interaction with rabphilin-11.
Finally, we examined whether the rabphilin-11-mSec13p interaction is
important in vesicle trafficking. For this purpose, we took advantage
of the VSV G protein transport system. VSV G protein is a membrane
protein encoded by the vesicular somatitis virus (which is transported
to the cell surface along the exocytic pathway) and can be utilized as
an ideal marker of vesicle trafficking (6, 26-28). As described (6),
in BHK cells, exogenously expressed GFP-tagged VSV G (GFP-VSV G)
protein accumulated in perinuclear regions, which presumably correspond
to the Golgi complex, by incubation at 20 °C for 2 h and was
transported to the plasma membrane by incubation at 37 °C for 1 h (Fig. 4A, a and
b). Overexpression of a Myc-tagged dominant negative mutant
of Rab11p (Rab11pT25N) markedly inhibited transport of GFP-VSV G
protein to the cell surface as compared with control cells (data not
shown), consistent with earlier observations (6). Similarly,
overexpression of the Rab11p-binding region of rabphilin-11 (Myc-tagged
rabphilin-11-5; 300-504 aa) or the mSec13p-binding region of
rabphilin-11 (Myc-tagged rabphilin-11-3; 504-631 aa) markedly
inhibited the transport of GFP-VSV G protein (Fig. 4B, a and
b). However, overexpression of Myc-tagged rabphilin-11-full
(data not shown) or Myc-tagged rabphilin-11-2 (300-631 aa), which
contains both the Rab11p-binding and mSec13p-binding regions, did not
affect this transport (Fig. 4Bc). These results, together
with the earlier observation that Rab11p regulates Golgi-to-plasma
membrane vesicle transport (6), suggest that the rabphilin-11-mSec13p
interaction is important in vesicle transport.
|
| |
DISCUSSION |
|---|
|
|
|---|
We have shown here that rabphilin-11 directly interacts with mSec13p by use of three different methods: yeast two-hybrid, affinity column chromatography, and immunoprecipitation. The interaction of full-length rabphilin-11 with mSec13p is weaker than that of the mSec13p-binding region of rabphilin-11 with mSec13p, suggesting that a region(s) other than the mSec13p-binding region masks this region and hinders the interaction with mSec13p. Consistently, the binding of GTP-Rab11p to full-length rabphilin-11 enhances its interaction with mSec13p, suggesting that the GTP-Rab11p-binding region may be such a region and that the binding of GTP-Rab11p to this region may directly or indirectly unfold the mSec13p-binding region. However, the enhancement by GTP-Rab11p does not reach the level of interaction of the mSec13p-binding region of rabphilin-11 with mSec13p. It has previously been proposed that there is some factor that promotes the unmasking of the GTP-Rab11p-binding region of rabphilin-11 (8), suggesting that a region(s) other than the GTP-Rab11p-binding region may also be involved in this masking and unfolding mechanism.
We have previously shown that rabphilin-11 is associated with membrane structures, presumably vesicles, in a GTP-Rab11p-dependent manner (9). The precise localization of mSec13p is not known, but by analogy with yeast Sec13p (10, 11), mSec13p may also localize on vesicles. If this is the case, one possible mechanism of the GTP-Rab11p-rabphilin-11-full-mSec13p interaction on vesicles is that GTP-Rab11p first binds to rabphilin-11 to make the folding structure open, eventually leading to the association of the GTP-Rab11p-rabphilin-11-mSec13p complex on the vesicles. The prenyl moiety of GTP-Rab11p may also be involved in the association of the complex with the vesicles, but the specific binding of the GTP-Rab11p-rabphilin-11 complex may be determined by the interaction with mSec13p.
It has been reported that yeast Sec13p participates in the formation of two different types of vesicles: the vesicles that bud from the late-Golgi complex (29) and COPII coated vesicles that bud from the ER (10-12, 17). In the former case, Sec13p may be involved in protein transport from the Golgi complex to the plasma membrane (29). We have shown here that mSec13p localizes in perinuclear regions, presumably the ER and the Golgi complex, where the GTP-Rab11p-rabphilin-11 complex colocalizes at the Golgi complex. In addition to these areas, the GTP-Rab11p-rabphilin-11 complex localizes to early endosomes, recycling endosomes, and secretory vesicles along microtubules oriented toward the plasma membrane (9). These results, together with earlier observations (9, 29), suggest that the rabphilin-11-mSec13p interaction regulates the transport of the vesicles budded from the Golgi complex to the microtubules oriented toward the plasma membrane. Once the vesicles ride on the microtubules, mSec13p may dissociate from the vesicles and be reutilized.
By analogy with yeast Sec13p, mSec13p may also be involved in the
budding process, at least from the Golgi complex, and this process may
be regulated by Arf small G proteins (30-33). Once the coated vesicles
are produced from the Golgi complex, they are uncoated and transported
to the plasma membrane along microtubules. Most Rab family members are
involved in the targeting/docking/fusion processes of vesicles to the
acceptor membranes (34-37). If Rab11p is also be involved in these
processes, the rabphilin-11-mSec13p interaction may functionally link
two different types of small G proteins, Arf and Rab proteins. Further
studies are necessary for our understanding of the mode of action of
the rabphilin-11-mSec13p interaction in vesicle trafficking.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Jennifer Lippincott-Schwartz (NICHD, National Institutes of Health, Bethesda, MD) for providing the plasmid encoding GFP-VSV G protein.
| |
FOOTNOTES |
|---|
* This investigation was supported by grants-in-aid for scientific research and for cancer research from the Ministry of Education, Science, Sports, and Culture, Japan (1999).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel: 81-66879-3410;
Fax: 81-66879-3419; E-mail: ytakai@molbio.med.osaka-u.ac.jp.
Published, JBC Papers in Press, March 9, 2000, DOI 10.1074/ jbc.C000096200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: aa, amino acids; COPII, coat proteins II; ER, endoplasmic reticulum; MBP, maltose-binding protein; PAGE, polyacrylamide gel electrophoresis; BHK, baby hamster kidney; VSV G protein, vesicular somatitis virus glycoprotein; GFP, green fluorescent protein; mSec13p, mammalian Sec13 protein.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Ohmori, T., Takeyama, Y., Ueda, T., Hiroyoshi, M., Nakanishi, H., Ohyanagi, H., Saitoh, Y., and Takai, Y. (1990) Biochem. Biophys. Res. Commun. 169, 816-823 |
| 2. | Chavrier, P., Vingron, M., Sander, C., Simons, K., and Zerial, M. (1990) Mol. Cell. Biol. 10, 6578-6585 |
| 3. | Sakurada, K., Uchida, K., Yamaguchi, K., Aisaka, K., Ito, S., Ohmori, T., Takeyama, Y., Ueda, T., Hori, Y., Ohyanagi, H., Saitoh, Y., Kaibuchi, K., and Takai, Y. (1991) Biochem. Biophys. Res. Commun. 177, 1224-1232 |
| 4. | Urbé, S., Huber, L. A., Zerial, M., Tooze, S. A., and Parton, R. G. (1993) FEBS Lett. 334, 175-182 |
| 5. | Ullrich, O., Reinsch, S., Urbé, S., Zerial, M., and Parton, R. G. (1996) J. Cell Biol. 135, 913-924 |
| 6. | Chen, W., Feng, Y., Chen, D., and Wandinger-Ness, A. (1998) Mol. Biol. Cell 9, 3241-3257 |
| 7. | Ren, M., Xu, G., Zeng, J., Lemos-Chiarandini, C. D., Adesnik, M., and Sabatini, D. D. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 6187-6192 |
| 8. | Zeng, J., Ren, M., Gravotta, D., Lemos-Chiarandini, C. D., Lui, M., Erdjument-Bromage, H., Tempst, P., Xu, G., Shen, T. H., Morimoto, T., Adesnik, M., and Sabatini, D. D. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 2840-2845 |
| 9. | Mammoto, A., Ohtsuka, T., Hotta, I., Sasaki, T., and Takai, Y. (1999) J. Biol. Chem. 274, 25517-25524 |
| 10. | Pryer, N. K., Salama, N. R., Schekman, R., and Kaiser, C. A. (1993) J. Cell Biol. 120, 865-875 |
| 11. | Salama, N. R., Yeung, T., and Schekman, R. (1993) EMBO J. 12, 4073-4082 |
| 12. | Barlowe, C., Orci, L., Yeung, T., Hosobuchi, M., Hamamoto, S., Salama, N. R., Rexach, M. F., Ravazzola, M., Amherdt, M., and Schekman, R. (1994) Cell 77, 895-907 |
| 13. | Nakano, A., Brada, D., and Schekman, R. (1988) J. Cell Biol. 107, 851-863 |
| 14. | d'Enfert, C., Barlowe, C., Nishikawa, S., Nakano, A., and Schekman, R. (1991) Mol. Cell. Biol. 11, 5727-5734 |
| 15. | Barlowe, C., and Schekman, R. (1993) Nature 365, 347-349 |
| 16. | Kuehn, M. J., Herrmann, J. M., and Schekman, R. (1998) Nature 391, 187-190 |
| 17. | Matsuoka, K., Orci, L., Amherdt, M., Bednarek, S. Y., Hamamoto, S., Schekman, R., and Yeung, T. (1998) Cell 93, 263-275 |
| 18. | Yoshihisa, T., Barlowe, C., and Schekman, R. (1993) Science 259, 1466-1468 |
| 19. | Tang, B. L., Peter, F., Krijnse-Locker, J., Low, S. H., Griffiths, G., and Hong, W. (1997) Mol. Cell. Biol. 17, 256-266 |
| 20. | Gietz, D., St. Jean, A., Woods, R. A., and Schiestl, R. H. (1992) Nucleic Acids Res. 20, 1425 |
| 21. | Kamei, T., Tanaka, K., Hihara, T., Umikawa, M., Imamura, H., Kikyo, M., Ozaki, K., and Takai, Y. (1998) J. Biol. Chem. 273, 28341-28345 |
| 22. | Guarente, L. (1983) Methods Enzymol. 101, 181-191 |
| 23. | Vojtek, A. B., Hollenberg, S. M., and Cooper, J. A. (1993) Cell 74, 205-214 |
| 24. | Miller, J. H. (1972) Experiments in Molecular Genetics , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 25. | Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 26. | Hughson, E., Wandinger-Ness, A., Gausepohl, H., Griffiths, G., and Simons, K. (1988) in Centenary Symposium of the Pasteur Institute (Schwartz, M., ed) , pp. 75-89, Elsevier, Paris |
| 27. | Bergmann, J. E. (1989) Laboratory Methods in Vesicular and Vectorial Transport , pp. 375-400, Academic Press, San Diego |
| 28. | Presley, J. F., Cole, N. B., Schroer, T. A., Hirschberg, K., Zaal, K. J. M., and Lippincott-Schwartz, J. (1997) Nature 389, 81-85 |
| 29. | Roberg, K. J., Rowley, N., and Kaiser, C. A. (1997) J. Cell Biol. 137, 1469-1482 |
| 30. | Donaldson, J. G., Cassel, D., Kahn, R. A., and Klausner, R. D. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 6408-6412 |
| 31. | Palmer, D. J., Helms, J. B., Beckers, C. J., Orci, L., and Rothman, J. E. (1993) J. Biol. Chem. 268, 12083-12089 |
| 32. | Stamnes, M. A., and Rothman, J. E. (1993) Cell 73, 999-1005 |
| 33. | Traub, L. M., Ostrom, J. A., and Kornfeld, S. (1993) J. Cell Biol. 123, 561-573 |
| 34. | Nuoffer, C., and Balch, W. E. (1994) Annu. Rev. Biochem. 63, 949-990 |
| 35. | Pfeffer, S. R. (1994) Curr. Opin. Cell Biol. 6, 522-526 |
| 36. | Takai, Y., Sasaki, T., Shirataki, H., and Nakanishi, H. (1996) Genes Cells 1, 615-632 |
| 37. | Novick, P., and Zerial, M. (1997) Curr. Opin. Cell Biol. 9, 496-504 |
This article has been cited by other articles:
![]() |
P.-Y. Gougeon, D. C. Prosser, L. F. Da-Silva, and J. K. Ngsee Disruption of Golgi Morphology and Trafficking in Cells Expressing Mutant Prenylated Rab Acceptor-1 J. Biol. Chem., September 20, 2002; 277(39): 36408 - 36414. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Segev Ypt/Rab GTPases: Regulators of Protein Trafficking Sci. Signal., September 18, 2001; 2001(100): re11 - re11. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takai, T. Sasaki, and T. Matozaki Small GTP-Binding Proteins Physiol Rev, January 1, 2001; 81(1): 153 - 208. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |